Amanote Research
Register
Sign In
HIV1 Integrase Strand Transfer Inhibitors With Reduced Susceptibility to Drug Resistant Mutant Integrases
doi 10.1021/acschembio.5b00948.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy
PLoS ONE
Multidisciplinary
Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer Inhibitors
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex
Journal of Molecular Biology
Structural Biology
Molecular Biology
Biophysics
Structure-Based Identification of HIV1 Nucleocapsid Protein Inhibitors Active Against Wild-Type and Drug-Resistant HIV1 Strains
Figure 1: FDA Approved Integrase Strand Transfer Inhibitors INSTIs: Raltegravir, Elvitegravir and Dolutegravir.
Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Preclinical Evaluation of 1h-Benzylindole Derivatives as Novel Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Altered Strand Transfer Activity of a Multiple-Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant With a Dipeptide Fingers Domain Insertion
Journal of Molecular Biology
Structural Biology
Molecular Biology
Biophysics
Drug Resistant Integrase Mutants Cause Aberrant HIV Integrations
Retrovirology
Virology
Infectious Diseases
